These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 8640827
1. Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis. Zhang L, Kashanchi F, Zhan Q, Zhan S, Brady JN, Fornace AJ, Seth P, Helman LJ. Cancer Res; 1996 Mar 15; 56(6):1367-73. PubMed ID: 8640827 [Abstract] [Full Text] [Related]
8. Dual role for transcription factor AP-2 in the regulation of the major fetal promoter P3 of the gene for human insulin-like growth factor II. Rietveld LE, Koonen-Reemst AM, Sussenbach JS, Holthuizen PE. Biochem J; 1999 Mar 15; 338 ( Pt 3)(Pt 3):799-806. PubMed ID: 10051455 [Abstract] [Full Text] [Related]
9. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers. Mathur RS, Mathur SP. Gynecol Oncol; 2005 Apr 15; 97(1):206-13. PubMed ID: 15790460 [Abstract] [Full Text] [Related]
10. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53. Wang Q, Beck WT. Cancer Res; 1998 Dec 15; 58(24):5762-9. PubMed ID: 9865734 [Abstract] [Full Text] [Related]
13. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma. Lee YI, Lee S, Das GC, Park US, Park SM, Lee YI. Oncogene; 2000 Aug 03; 19(33):3717-26. PubMed ID: 10949925 [Abstract] [Full Text] [Related]